(Q37888687)

24 August 2017

1 reference

title

Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation (English)

1 reference

stem cell transplantation

24 August 2017

main subject

1 reference

Simone Thomas

1

1 reference

24 August 2017

Wolfgang Herr

series ordinal

2

1 reference

24 August 2017

publication date

1 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

3

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

771-788

1 reference

Genetic content of wild-type human cytomegalovirus

24 August 2017

cites work

1 reference

Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome

21 January 2018

1 reference

Coding potential of laboratory and clinical strains of human cytomegalovirus

21 January 2018

1 reference

The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome

21 January 2018

1 reference

Cytomegalovirus reactivation in critically ill immunocompetent patients

21 January 2018

1 reference

CMV in critically ill patients: pathogen or bystander?

21 January 2018

1 reference

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

21 January 2018

1 reference

Human cytomegalovirus and immunopathology.

21 January 2018

1 reference

CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation

21 January 2018

1 reference

Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection

21 January 2018

1 reference

Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection

21 January 2018

1 reference

Properties of CD4(+) T cells in human cytomegalovirus infection

21 January 2018

1 reference

Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

21 January 2018

1 reference

Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals.

21 January 2018

1 reference

Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

21 January 2018

1 reference

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

21 January 2018

1 reference

Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells

21 January 2018

1 reference

Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.

21 January 2018

1 reference

Identification of cytomegalovirus-specific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes

21 January 2018

1 reference

T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection.

21 January 2018

1 reference

Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection

21 January 2018

1 reference

Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

21 January 2018

1 reference

Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

21 January 2018

1 reference

Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals

21 January 2018

1 reference

Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response

21 January 2018

1 reference

Clinical aspects of CMV infection after stem cell transplantation

21 January 2018

1 reference

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.

21 January 2018

1 reference

Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation

21 January 2018

1 reference

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

21 January 2018

1 reference

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

21 January 2018

1 reference

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

21 January 2018

1 reference

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

21 January 2018

1 reference

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

21 January 2018

1 reference

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.

21 January 2018

1 reference

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

21 January 2018

1 reference

Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study

21 January 2018

1 reference

Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.

21 January 2018

1 reference

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

21 January 2018

1 reference

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

21 January 2018

1 reference

Gammadelta T cells: functional plasticity and heterogeneity

21 January 2018

1 reference

Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection

21 January 2018

1 reference

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.

21 January 2018

1 reference

Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

21 January 2018

1 reference

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

21 January 2018

1 reference

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

21 January 2018

1 reference

Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation.

21 January 2018

1 reference

Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy

21 January 2018

1 reference

Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation

21 January 2018

1 reference

Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells

21 January 2018

1 reference

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.

21 January 2018

1 reference

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

21 January 2018

1 reference

Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting

21 January 2018

1 reference

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

Five donors-one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors

21 January 2018

1 reference

Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells

21 January 2018

1 reference

In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes

21 January 2018

1 reference

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

21 January 2018

1 reference

Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy

21 January 2018

1 reference

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

Signaling control of memory T cell generation and function

21 January 2018

1 reference

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice

21 January 2018

1 reference

Infusion of cytomegalovirus specific cytotoxic T lymphocytes from a sero-negative donor can facilitate resolution of infection and immune reconstitution.

21 January 2018

1 reference

Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation

21 January 2018

1 reference

Epstein-Barr virus: new insights

21 January 2018

1 reference

A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis

21 January 2018

1 reference

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

21 January 2018

1 reference

EBV persistence in memory B cells in vivo.

21 January 2018

1 reference

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

21 January 2018

1 reference

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

21 January 2018

1 reference

Epstein-Barr virus strategy in normal and neoplastic B cells

21 January 2018

1 reference

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

21 January 2018

1 reference

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

21 January 2018

1 reference

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1

21 January 2018

1 reference

Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target

21 January 2018

1 reference

Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders

21 January 2018

1 reference

Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response

21 January 2018

1 reference

The complexity of the Epstein-Barr virus infection in humans

21 January 2018

1 reference

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

21 January 2018

1 reference

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

21 January 2018

1 reference

21 January 2018

1 reference

Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

21 January 2018

1 reference

Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection

21 January 2018

1 reference

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

21 January 2018

1 reference

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses

21 January 2018

1 reference

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses

21 January 2018

1 reference

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy

21 January 2018

1 reference

Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease

21 January 2018

1 reference

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

21 January 2018

1 reference

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

21 January 2018

1 reference

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

21 January 2018

1 reference

Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease

21 January 2018

1 reference

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

21 January 2018

1 reference

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

21 January 2018

1 reference

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.

21 January 2018

1 reference

Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy

21 January 2018

1 reference

Homeostatic competition among T cells revealed by conditional inactivation of the mouse Cd4 gene

21 January 2018

1 reference

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

21 January 2018

1 reference

Allo-HLA reactivity of virus-specific memory T cells is common

21 January 2018

1 reference

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects

21 January 2018

1 reference

Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine

21 January 2018

1 reference

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults

21 January 2018

1 reference

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

21 January 2018

1 reference

A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation.

21 January 2018

1 reference

Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis

21 January 2018

1 reference

The complete DNA sequence of varicella-zoster virus

21 January 2018

1 reference

Evolution and world-wide distribution of varicella-zoster virus clades

21 January 2018

1 reference

Humoral and cellular immunity to varicella-zoster virus: an overview

21 January 2018

1 reference

Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression

21 January 2018

1 reference

Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.

21 January 2018

1 reference

Cell-Mediated Immunity to Varicella-Zoster Virus after Allogeneic Marrow Transplant

21 January 2018

1 reference

Subclinical Varicella-Zoster Virus Viremia, Herpes Zoster, and T Lymphocyte Immunity to Varicella-Zoster Viral Antigens after Bone Marrow Transplantation

21 January 2018

1 reference

Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients

21 January 2018

1 reference

Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster

21 January 2018

1 reference

Herpes simplex and varicella zoster viruses: forgotten but not gone

21 January 2018

1 reference

Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients

21 January 2018

1 reference

The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation

21 January 2018

1 reference

One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation

21 January 2018

1 reference

Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation

21 January 2018

1 reference

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

Varicella-zoster reactivation in a patient receiving routine revaccinations after an allogeneic hemopoietic progenitors transplant

21 January 2018

1 reference

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

21 January 2018

1 reference

Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.11.47

1 reference

24 August 2017

1 reference